International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Changjiang Liuyu Ziyuan Yu Huanjing/Resources and Environment in the Yangtze Valley Shenyang Jianzhu Daxue Xuebao (Ziran Kexue Ban)/Journal of Shenyang Jianzhu University (Natural Science) General Medicine (ISSN:1311-1817) Chinese Journal of Evidence-Based Medicine Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation Lizi Jiaohuan Yu Xifu/Ion Exchange and Adsorption Kexue Tongbao/Chinese Science Bulletin Dalian Haishi Daxue Xuebao/Journal of Dalian Maritime University

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-07-04-2022-1365
Total View : 470

Abstract : Stroke is the syndrome in which the cerebral dysfunction occurs and the symptoms last more than 24 hours which leads to death. There are different approaches that are used for the treatment of spasticity of upper limb in stroke patients like Bobath / Neurodevelopmental Treatment Approach and Motor Relearning Program. The objective of the study is to find out the comparison of Bobath / Neurodevelopmental Treatment Vs Motor Relearning Program for the spasticity of upper limb in chronic stroke patients. Study design was a randomized control trial with 80 sample size randomely allocated into MRP and NDT groups. Patients of around age of 45-70 were taken and both groups received routine physiotherapy as a baseline treatment approach and one group received MRP and the other received NDT for 8 weeks. The study was single blinded i.e the assessor was kept blinded. The pre test Mean Modified Ashworth Scale spasticity level of both groups was equal 2.73±0.640. After 4 weeks the mean Spasticity of Bobath / NDT group was 1.83±0.549 and the mean spasticity of MRP group was 1.48±0.640 which is quite less than Bobath / NDT group. After 8 weeks when the treatment ended the mean spasticity of Bobath / NDT group was 1.13±0.607 and the mean spasticity of MRP group was 0.65±0.622 which was significantly less than Bobath / NDT group. Both of the treatment approaches have proven to be effective in treatment of spasticity of upper limb among chronic stroke patients but the Motor Relearning Program has proven to be significantly more effective than Neurodevelopmental Treatment and has reduced Spasticity more efficiently..
Full article
International Medical Journal
Journal ID : IMJ-31-03-2022-1353
Total View : 423

Abstract : Skin illnesses, such as acne vulgaris, have psychological effects for those who suffer from them, causing sense of guilt, shame, and social withdrawal. The onset of acne vulgaris throughout puberty renders this condition a main point of concerns for many people since teenagers are psychologically extremely disturbed. The current study aims to measure the effects of acne on female secondary school students in Al-Najaf City. An observational case-control design has been conducted in secondary schools at Al-Najaf city starting from 1st of November 2021 to 3rd of July 2022. The sample was acquired using a non-probability purposive sample of 200 female students with acne and 200 female students without acne, which was developed by the researcher using a self-administrative questionnaire to meet the study's aims. The questionnaire's validity and reliability were assessed by experts and cronbach's alpha, respectively, while the respondents employed the questionnaire as a self-report technique. According to the findings of the study, female students with acne have a significantly lower level of self-esteem than female students without acne. The study has concluded that the case group have low self-esteem level as compare control group because they are girls in this age group and are attending college focusing on self-centered and force of personality, it is normal for them to have sentiments of low self because they have been withdrawn, get less connections with others, and have a lowered body self-image, even if they have poor self..
Full article
International Medical Journal
Journal ID : IMJ-28-03-2022-1351
Total View : 391

Abstract : To evaluate cytotoxic and antiviral potential of Moxidectin and Amantadine against influenza virus H9. The cytotoxicity of moxidectin and amantadine was evaluated on primary fibroblast cell line through MTT assay. Antiviral activity in vitro and in vivo was tested on 9-days old chick embryo. Cytotoxicity and antiviral activity of Moxidectin is high at first two conc. 200µg/ml and 100µg/ml while safe at lower conc. 50, 25, 12.5 and 6.25µg/ml. Antiviral activity of Amantadine is strong at all conc. 200µg/ml, 100µg/ml, 50µg/ml, 25µg/ml, 12.5µg/ml and 6.25µg/ml. All the concentrations of Amantadine were non-cytotoxic with higher safety profile. It was concluded that concentrations of moxidectin 200 and 100µg/ml were cytotoxic and lower concentrations were safe. All the concentrations of Amantadine were non-cytotoxic. Moxidectin at 200 and 100µg/ml demonstrated strong antiviral potential and antiviral potential decreased as concentrations decreased. Amantadine showed strong antiviral activity against influenza virus H9 at all concentrations..
Full article
International Medical Journal
Journal ID : IMJ-27-03-2022-1349
Total View : 402

Abstract : The main goal of this study was to determine the prevalence and duration of acute loss of smell and taste in COVID-19 patients who visit Anwar Hospital, Saidu Sharif Swat. Initially, acute loss of smell (anosmia) and taste (ageusia) was not thought to be significant COVID-19 symptoms. To find out how often certain symptoms are and how important they are in terms of diagnosis. Cross-sectional retrospective study was conducted at Anwar Hospital, Anwar Clinical Laboratory, Saidu Sharif Swat, KPK, Pakistan from 01 March 2020 to 18 September 2021. A total of 3537 specimens of the suspected COVID-19 patients were tested using Real-Time Polymerase Chain Reaction (RT-PCR). In the current study it was found that 4.8% (45) patients had a loss of taste and smell. The patients were under observation for a duration of 2-3 weeks (8 to 21 days). The RT-PCR of 970 patients was positive whereas of 1567 was negative. The prevalence of COVID-19 was 38.23%. All participants' ages ranging from 9 to 70 years were included in this study. Ageusia and Anosmia appear to be key symptoms and indicators for COVID-19 diagnosis, especially when the illness is in its early stages. Majority of the COVID-19 patients, who had anosmia or ageusia recovered in three weeks. For both symptoms, the median duration to recovery was 7 days. In individuals with suspected COVID-19, these symptoms might be a valuable tool for early diagnostic work-up..
Full article
International Medical Journal
Journal ID : IMJ-27-03-2022-1348
Total View : 429

Abstract : Multiple sclerosis is an immune mediated disease affecting the central nervous system, which lead to neurodegenerative causes of physical disability globally. Relationship of non-human leukocyte antigen gene, CD58, with multiple sclerosis has been reported in many populations but is indistinct among Southwest Asians. Our study was established to explore the association between CD58 polymorphism and multiple sclerosis among the Iraqi population in Iraq. This study was conducted to analyzed the frequency of rs12044852 polymorphism and its consequence on the genetic susceptibility to Multiple sclerosis. Case control study was conducted on 30 MS patients and equal number of healthy controls was recruited to be genotyped in an experimental case-control based study through polymerase chain reaction using specific sequence primers (PCR-SSP). Results of CD58 Genotyping showed that there is a significant effect of the frequency of rs12044852 within the genetic susceptibility of MS. So, a Strong association was found between the CC genotype and onset of MS (L.S.D 0.05) and the AC genotype was more frequent in the control. Our findings revealed the (critical effect of rs12044852 poly-morphism of CD58 on the MS susceptibility..
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//